Strokes remain among the leading causes of death and disability worldwide, often developing from underlying health conditions that frequently go undet ...
Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...
Joelle suffered a hemorrhagic stroke on Dec. 16, leaving her with significant challenges and a long road to recovery. Now, the community is coming together to support her and her family. The ordeal ...